Ziebes 1 the market is discounting 1 Ryoncil sale per week on average over the next 12 months (Ryoncil DCF valuation $1.54).
And we must wait for an update from Mesoblast to confirm or deny. We do not know if recent treatments have been successful?
The market hates uncertainty and the communication strategy has allowed short sellers to feed on Mesoblast and created selling from at least 2 institutions whom participated in the $2.50 placement.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
-0.055(2.97%) |
Mkt cap ! $2.293B | |||
| Open | High | Low | Value | Volume |
| $1.84 | $1.86 | $1.77 | $7.241M | 4.018M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25472 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |